Regeneron Pharmaceuticals, Inc. (REGN)
783.79
+4.82
(+0.62%)
USD |
NASDAQ |
Feb 12, 16:00
783.60
-0.19
(-0.02%)
After-Hours: 20:00
Regeneron Pharmaceuticals Cash from Investing (Quarterly) : 220.30M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.171B |
| Cash from Financing (Quarterly) | -780.10M |
| Free Cash Flow | 3.765B |
| Free Cash Flow Per Share (Quarterly) | 8.186 |
| Free Cash Flow to Equity (Quarterly) | 612.80M |
| Free Cash Flow to Firm (Quarterly) | 889.87M |
| Free Cash Flow Yield | 4.42% |